129
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Enaminones as Building Blocks in Heterocyclic Synthesis: Novel Routs for Synthesis of Coumarin Analogs and Study their Anticancer Activities

, & ORCID Icon
Pages 1581-1592 | Received 28 Jun 2022, Accepted 05 Apr 2023, Published online: 20 Apr 2023
 

Abstract

A novel series of coumarins linked to benzo[b][1,4]oxazepin, benzo[b][1,4]thiazepin, and benzo[b][1,4]diazepin were synthesized via the reaction of 6-bromo-3-(3-(dimethylamino) acryloyl)-2H-chromen-2-one (2) with o-aminophenol, o-aminothiophenol or o-phenylenediamine. Also, enaminone 2 was reacted with heterocyclic amine or ethylenediamine afforded coumarin derivatives 14–16. Furthermore, pyrazole derivatives 20–22 were accomplished by interaction of enaminone 2 with benzoyl hydrazine, 2-cyanoacetic acidhydrazide, and thiocarbohydrazide, correspondingly. Finally, interaction of enaminone 2 with different sulphadrugs afforded sulfonamides 24a–c. The anticancer activity of the new coumarins was conducted at NCI/USA toward a panel of 60 cancer cell lines including leukemia, lung, colon, melanoma, ovarian, CNS, prostate, renal, and breast cancers. Data analysis showed that, compound 20 showed the highest activity toward all cancer cell lines with GI% range from 95 to 51. It has a lethal effect against some cells including leukemia HL-60(TB)(−13.46), non-small cell lung cancer EKVX (−1.71), melanoma M14 (−4.71), UACC-62 (−21.14), ovarian cancer NCI/ADR-RES (−2.98) and breast cancer MCF7 (−8.53), and MDA-MB-468 (−25.86).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.